Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)
The ULYSSE study, based in Lyon, France, is a research project focused on understanding lung cancer and other chest cancers better. It involves collecting information, blood samples, and details from scans and other tests from patients over time. The main goal is to create a comprehensive database that researchers can use to learn more about how these cancers develop and respond to treatment. This knowledge could lead to new and better ways to diagnose and treat these conditions in the future, ultimately improving patient care for people affected by thoracic cancers.
At a glance
What is this study about?
The ULYSSE study (which stands for Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE) is a research project happening in Lyon, France. Researchers are collecting a lot of different information from people who have been diagnosed with lung cancer or other similar cancers in the chest area, like mesothelioma.
Imagine creating a very detailed picture of these cancers over time. That's what the researchers are doing. They're gathering medical details, taking blood samples, and looking at information from scans and other tests. By collecting all this information in one place, they can study how these cancers behave, how they respond to different treatments, and what factors might influence a person's journey. This helps scientists understand the diseases much better.
Why is this important? By building such a detailed collection of information and samples, researchers can look for patterns and clues that aren't obvious when studying individual cases. This can lead to breakthroughs in understanding these complex diseases, which could eventually help doctors find new and more effective ways to prevent, diagnose, and treat lung and other thoracic cancers in the future. It's all about improving care for patients.
Key takeaways
- It's a study for people with lung or other chest cancers being treated at Lyon University Hospital.
- Researchers collect information and samples to better understand these cancers.
- Participation involves giving blood samples and answering questionnaires.
- It works alongside your regular medical care; no new drugs or extra visits.
- Information gathered could help improve future treatments for cancer patients.
- You can withdraw from the study at any time.
Who may be eligible?
To be considered for this study, you would need to be a patient receiving treatment for a cancer in the chest area at the Lyon University Hospital in France. This includes common types like non-small cell lung cancer, small cell lung cancer, or other specific chest cancers such as mesothelioma.
Your cancer diagnosis would typically have been confirmed by samples, or sometimes by a decision made by a team of specialist doctors. This can happen if, for example, you're having radiation treatment without a physical sample, or if treatment starts based on special blood tests.
There are also some reasons why you might not be able to join. If you decide you don't want to take part, that's perfectly fine. Also, if your weight is less than 30 kilograms, or if there's no suitable plan for collecting blood as part of your regular care, you might not be able to provide blood samples for the study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you being treated for a cancer in your chest (like lung cancer or mesothelioma)?
- Are you receiving your treatment at the Lyon University Hospital in France?
- Has your cancer been diagnosed by samples, or by a team of specialist doctors?
- Are you willing to provide blood samples and answer questionnaires?
- Do you weigh more than 30 kilograms (if planning to give blood for the study)?
What does participation involve?
If you decide to take part in this study, it largely works alongside your regular medical care. You won't be given any new medications specifically for the study. Instead, the researchers will collect information and samples as you go through your usual treatment.
This will involve providing blood samples, which would usually be taken when you're already having blood tests for your general medical care. You will also be asked to complete questionnaires. The researchers will also gather information from your medical records, including details from your scans and pathology reports (from tissue samples).
There are no additional clinic visits specifically for this study. The duration of your participation will depend on the length of your treatment and follow-up at the hospital, as information will be collected over time (this is what is meant by 'longitudinal').
Potential risks and benefits
Locations (1)
- Centre Hospitalier Lyon SudVerified postcodePierre-Bénite, France· Recruiting
Common questions
What kind of cancer patients are being studied?
The study focuses on patients with lung cancer (both small cell and non-small cell) and other chest cancers like mesothelioma, who are being treated at Lyon University Hospital in France.
Do I have to take any new medicines for this study?
No, you won't be given any new medicines. This study collects information and samples from your standard medical care.
Will I have extra hospital visits for the study?
No, there are no extra hospital visits required specifically for this study. It integrates with your existing appointments.
What does 'blood sample' involve?
Blood samples for the study will typically be taken at the same time as any blood tests you are already having for your general medical care.
Can I change my mind about being in the study?
Yes, absolutely. You can decide to leave the study at any time, and this will not affect the medical care you receive.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.